Please provide your email address to receive an email when new articles are posted on . In the quest for practical strategies for treating obesity, intermittent fasting has emerged as a popular and ...
Vial's INHBE siRNA is a first-in-class, liver-targeted (GalNAc-conjugated) siRNA therapy that silences INHBE and its gene product, Activin E Leading key opinion leaders (KOLs) Drs. Jason Fung, Scott ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback